due to IgA nephropathy subsequent to therapy | ||||
Response groups | No. | Sex | Age* | Duration of follow up* |
(F/M) | (years) | (months) | ||
Responsive | 5 | 2/3 | 27 ± 3 | 35 ± 10 |
Partially responsive | 2 | 0/2 | 29 ± 2 | 34 ± 5 |
Total | 7 | 2/5 | 28 ± 3 | 35 ± 8 |